Literature DB >> 14971883

Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions?

Maria Tsoumakidou1, Nikolaos Tzanakis, Olga Voulgaraki, Ioanna Mitrouska, Georgios Chrysofakis, Maria Samiou, Nikolaos M Siafakas.   

Abstract

Disagreement exists between different COPD guidelines considering classification of severity of the disease. The aim of our study was to determine whether there is any correlation between severity scales of various COPD guidelines (ATS, BTS, ERS and GOLD) and the frequency of hospitalisations for COPD exacerbation. A cohort of 67 COPD patients (65 male 2 female, 45 ex-smokers, 22 current smokers, aged (69.4 +/- 1.1)) was recruited from those admitted in the pulmonary clinic of the University Hospital of Heraklion, Crete for an acute exacerbation. Lung function tests and arterial blood gases analyses were performed during stable conditions at a scheduled visit 2 months after discharge. The patients were stratified using the FEV1 percent-predicted measurement of this visit into mild, moderate and severe in accordance to the ATS, BTS, ERS and GOLD scales of severity. The number of hospitalisations for acute exacerbation was recorded for the following 18 months. A total of 165 exacerbations were recorded. The correlation between the severity of COPD and the number of hospitalisations per year was statistically significant using the GOLD classification system of severity (P = 0.02 and r = 0.294). A weak correlation was also found between the number of hospitalisations and the ERS classification system (P = 0.05 and r = 0.24). No statistically significant correlation was found between the number of hospitalisations and the ATS or BTS severity scales. In conclusion the GOLD and ERS classification systems of severity of COPD correlated to exacerbations causing hospitalisation. The same was not true for the ATS and BTS severity scales. Better correlation was achieved with the GOLD scale.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971883     DOI: 10.1016/j.rmed.2003.09.011

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  9 in total

1.  Readmission Due to Exacerbation of COPD: Associated Factors.

Authors:  Alicia Cerezo Lajas; Enrique Gutiérrez González; César Llorente Parrado; Luis Puente Maestu; Javier de Miguel-Díez
Journal:  Lung       Date:  2018-02-14       Impact factor: 2.584

Review 2.  [Assessment, triage, and follow-up of a patient with: acute CAP COPD].

Authors:  K Faure
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

Review 3.  Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review.

Authors:  Kokuvi Atsou; Christos Chouaid; Gilles Hejblum
Journal:  BMC Med       Date:  2011-01-18       Impact factor: 8.775

4.  Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD.

Authors:  Harry Rea; Timothy Kenealy; Jacqui Adair; Elizabeth Robinson; Nicolette Sheridan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-10-14

Review 5.  Predicting and preventing hospital readmission for exacerbations of COPD.

Authors:  Chia Wei Kong; Tom M A Wilkinson
Journal:  ERJ Open Res       Date:  2020-05-11

6.  Adequate Patient Characterization in COPD: Reasons to Go Beyond GOLD Classification.

Authors:  Tewe L Verhage; Yvonne F Heijdra; Johan Molema; Leonie Daudey; P N Richard Dekhuijzen; Jan H Vercoulen
Journal:  Open Respir Med J       Date:  2009-02-13

7.  The need to further understand who gets hospitalized for a COPD exacerbation.

Authors:  Diego J Maselli; Antonio Anzueto
Journal:  Multidiscip Respir Med       Date:  2012-06-19

8.  Association between Severity of Chronic Obstructive Pulmonary Disease and Lung Function Tests.

Authors:  Hamid Reza Jamaati; Bahareh Heshmat; Ronak Tamadon; Abbas Hamidi Rad; Seyed Amir Mohajerani; Golnar Radmand; Seyed Mohammad Reza Hashemian
Journal:  Tanaffos       Date:  2013

9.  Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.

Authors:  Miguel Santibáñez; Roberto Garrastazu; Mario Ruiz-Nuñez; Jose Manuel Helguera; Sandra Arenal; Cristina Bonnardeux; Carlos León; Juan Luis García-Rivero
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.